“[The Teal Wand] offers an evidence-based way to expand access [to screening] without compromising accuracy,” according to Christine Conageski, MD, MSc, from the University of Colorado Anschutz Medical Campus.
The Teal Wand™, an at-home vaginal sample self-collection device for cervical cancer screening, has been approved by the FDA, according to a press release from the developer, Teal Health.1
The at-home screening kit is intended for patients aged 25 to 65. Additionally, patients will have virtual access to medical providers who will prescribe the kit and review the results.
The approval was based on data from the SELF-CERV study (NCT06120205), which assessed more than 600 patients across 16 study sites in the US.2 The primary end point was positive percent agreement, in which the study identified HPV-positive…